Profile image
By marketresearchnest
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Head And Neck Cancer Therapeutics Pipeline Market H1 2017

Thursday, May 18, 2017 5:04
% of readers think this story is Fact. Add your two cents.

(Before It's News) adds “Head And Neck Cancer – Pipeline Review, H1 2017” new report to its research database. The report spread across in multiple pages with table and figures in it.


Latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H1 2017, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Browse full table of contents and data tables at

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 18, 87, 98, 5, 92, 17 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 11, 6, 1, 15 and 3 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Head And Neck Cancer – Companies Involved in Therapeutics Development

3SBio Inc


AB Science SA

AbbVie Inc

Abion Inc

Accelerated Pharma Inc

Acceleron Pharma Inc

Adaptimmune Therapeutics Plc

Aduro BioTech Inc

Advaxis Inc

Advenchen Laboratories LLC

Affimed GmbH

Altor BioScience Corp

Ambrx Inc

amcure GmbH

Amgen Inc


ArQule Inc

Array BioPharma Inc

Aspyrian Therapeutics Inc

Astellas Pharma Inc

AstraZeneca Plc

Atara Biotherapeutics Inc


AVEO Pharmaceuticals Inc

Bayer AG

BeiGene Ltd

Benitec Biopharma Ltd

Beta Pharma Inc

Bexion Pharmaceuticals LLC

BioDiem Ltd

Biomics Biotechnologies Co Ltd

Bionovis SA

BioNTech AG

Biotest AG

Biothera Pharmaceutical Inc

Boehringer Ingelheim GmbH

Boston Biomedical Inc

Bristol-Myers Squibb Company

CBT Pharmaceuticals Inc

Celgene Corp

Cell Medica Ltd

Cellceutix Corp

Celldex Therapeutics Inc

Celprogen Inc

Centrose LLC

Corvus Pharmaceuticals Inc

Cristal Therapeutics BV

Critical Outcome Technologies Inc

CytImmune Sciences Inc

Daiichi Sankyo Company Ltd

Denceptor Therapeutics Ltd

DNJ Pharma Inc

Dynavax Technologies Corp

Eisai Co Ltd

Eleven Biotherapeutics Inc

Eli Lilly and Company

Etubics Corp

Eureka Therapeutics Inc

F. Hoffmann-La Roche Ltd

Five Prime Therapeutics Inc

Forty Seven Inc

Fujifilm Corp

G&E Herbal Biotechnology Co Ltd

Galectin Therapeutics Inc

Genelux Corp

GeneSegues Inc

Genexine Inc

Genmab A/S

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

Gliknik Inc

Glycotope GmbH

Griffith University

Hanmi Pharmaceuticals Co Ltd

Hookipa Biotech AG

Horizon Pharma Plc

Hutchison China MediTech Ltd

Ignyta Inc

Immunocore Ltd

Immunomedics Inc

Immunovaccine Inc

Immunovative Therapies Ltd

Incyte Corp

Infinity Pharmaceuticals Inc

Innate Pharma SA

Inovio Pharmaceuticals Inc

InteRNA Technologies BV

Ipsen SA

IRX Therapeutics Inc

ISA Pharmaceuticals BV


Jiangsu Hengrui Medicine Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Johnson & Johnson

Juno Therapeutics Inc

Kite Pharma Inc

Kura Oncology Inc

And Many More


Order a Purchase Report Copy at


Scope of this Report

- The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)


Request Sample Copy at


About Us:                  is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.


Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]


Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.